Hemorrhagic moyamoya disease—benefits of revascularization

• References

• 1 Smith ER, Scott RM. Moyamoya: Epidemiology, presentation, and diagnosis. Neurosurg Clin N Am 2010; 21: 543-551
• 2 Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke 2011; 42: 3304-3310
• 3 Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 2000; 93: 976-980
• 4 Ikezaki K, Fukui M, Inamura T, Kinukawa N, Wakai K, Ono Y. The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan. Clin Neurol Neurosurg 1997; 99 (Suppl. 02) S183-S186
• 5 Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?. Stroke 1996; 27: 1342-1346
• 6 Miyamoto S. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset-the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 2004; 44: 218-219